Clinical trial
An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive…
NCT00091845 · Sarepta Therapeutics, Inc., Industry · Terminated
Key facts
| NCT number | NCT00091845 |
|---|---|
| Title | An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease |
| Official title | An Exploratory Study of the Safety, Tolerability, Pharmacokinetics and Potential Effectiveness of AVI-4020 Injection in Patients Presenting With Presumptive Acute Neuroinvasive West Nile Virus (WNV) Disease |
| Lead sponsor | Sarepta Therapeutics, Inc., Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | West Nile Fever |
| Intervention type | Drug |
| Interventions | AVI-4020 Injection |
| Enrollment | 50 |
| Start date | Nov 1, 2004 |
| Completion | Nov 1, 2004 |
| First posted | Sep 21, 2004 |
| Last update posted | Jul 8, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: